H. B. Fuller (NYSE:FUL) Stock Rating Lowered by ValuEngine

H. B. Fuller (NYSE:FUL) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Friday, November 10th.

Several other brokerages also recently commented on FUL. Deutsche Bank lifted their target price on H. B. Fuller from $56.00 to $58.00 and gave the stock a “hold” rating in a research note on Wednesday, September 6th. Zacks Investment Research downgraded H. B. Fuller from a “hold” rating to a “sell” rating in a research note on Thursday, September 21st. Citigroup downgraded H. B. Fuller from a “buy” rating to a “neutral” rating and set a $60.00 price target for the company. in a research note on Tuesday, October 31st. Robert W. Baird started coverage on H. B. Fuller in a research note on Thursday, September 14th. They issued a “neutral” rating and a $60.00 price target for the company. Finally, KeyCorp restated a “hold” rating on shares of H. B. Fuller in a research note on Thursday, August 24th. One investment analyst has rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $57.60.

Shares of H. B. Fuller (NYSE:FUL) traded down $0.58 during trading on Friday, reaching $56.63. The company had a trading volume of 411,600 shares, compared to its average volume of 318,669. H. B. Fuller has a 1-year low of $45.82 and a 1-year high of $58.74. The firm has a market cap of $2,840.00, a price-to-earnings ratio of 22.54 and a beta of 1.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.72 and a current ratio of 2.63.

H. B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, September 27th. The specialty chemicals company reported $0.65 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.67 by ($0.02). The company had revenue of $562.87 million for the quarter, compared to analyst estimates of $553.66 million. H. B. Fuller had a return on equity of 13.08% and a net margin of 4.76%. analysts anticipate that H. B. Fuller will post 2.6 EPS for the current fiscal year.

In other H. B. Fuller news, VP Timothy J. Keenan sold 6,500 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $55.08, for a total value of $358,020.00. Following the completion of the transaction, the vice president now owns 29,611 shares of the company’s stock, valued at approximately $1,630,973.88. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Robert J. Martsching sold 3,870 shares of the company’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $57.93, for a total value of $224,189.10. The disclosure for this sale can be found here. Insiders have sold a total of 15,767 shares of company stock valued at $897,394 in the last three months. 3.10% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of FUL. Janus Henderson Group PLC bought a new stake in shares of H. B. Fuller during the 2nd quarter valued at about $105,912,000. Principal Financial Group Inc. boosted its position in shares of H. B. Fuller by 141.0% during the 2nd quarter. Principal Financial Group Inc. now owns 977,899 shares of the specialty chemicals company’s stock valued at $49,980,000 after purchasing an additional 572,177 shares in the last quarter. Westfield Capital Management Co. LP boosted its position in shares of H. B. Fuller by 135.7% during the 3rd quarter. Westfield Capital Management Co. LP now owns 476,700 shares of the specialty chemicals company’s stock valued at $27,677,000 after purchasing an additional 274,433 shares in the last quarter. Pioneer Investment Management Inc. bought a new stake in shares of H. B. Fuller during the 2nd quarter valued at about $11,091,000. Finally, Amundi Pioneer Asset Management Inc. boosted its position in shares of H. B. Fuller by 92.4% during the 3rd quarter. Amundi Pioneer Asset Management Inc. now owns 417,610 shares of the specialty chemicals company’s stock valued at $24,247,000 after purchasing an additional 200,594 shares in the last quarter. 92.34% of the stock is owned by institutional investors.

WARNING: “H. B. Fuller (NYSE:FUL) Stock Rating Lowered by ValuEngine” was first reported by BBNS and is the sole property of of BBNS. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://baseballnewssource.com/markets/h-b-fuller-company-ful-cut-to-hold-at-valuengine/1774874.html.

About H. B. Fuller

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for H. B. Fuller (NYSE:FUL)

Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.